Sarissa Capital Management LP Long-Term Concentrated

CIK: 0001577524 · Show all filings

Period: Q2 2014 (← Previous) (Next →)

Filing Date: Aug 14, 2014

Total Value ($000): $294,075 (100.0% shares, 0.0% debt)

Holdings (15)

— ARIAD PHARMACEUTICALS INC 26.0%

Value ($000) $76,440 Shares 12,000,000 Est. Cost $6.82 Unrealized —

— IDENIX PHARMACEUTICALS INC 16.4%

Value ($000) $48,200 Shares 2,000,000 Est. Cost $5.98 Unrealized —

DGX QUEST DIAGNOSTICS INC 15.5%

Value ($000) $45,485 Shares 775,000 Est. Cost $46.05 Unrealized +0.7%

— BIO-REFERENCE LABS INC 13.2%

Value ($000) $38,711 Shares 1,280,984 Est. Cost $27.20 Unrealized —

MRK MERCK & CO INC NEW 7.9%

Value ($000) $23,140 Shares 400,000 Est. Cost $31.29 Unrealized +21.3%

— REPROS THERAPEUTICS INC 5.9%

Value ($000) $17,358 Shares 1,003,367 Est. Cost $17.80 Unrealized —

— VIVUS INC 4.7%

Value ($000) $13,693 Shares 2,573,943 Est. Cost $9.08 Unrealized —

AMGN AMGEN INC 1.8%

Value ($000) $5,327 Shares 45,000 Est. Cost $83.37 Unrealized 0.0%

— AVEO PHARMACEUTICALS INC 1.6%

Value ($000) $4,704 Shares 2,570,759 Est. Cost $1.84 Unrealized —

ENTA ENANTA PHARMACEUTICALS INC 1.5%

Value ($000) $4,522 Shares 105,000 Est. Cost $37.28 Unrealized +2.3%

— KINDRED BIOSCIENCES INC 1.4%

Value ($000) $4,252 Shares 228,126 Est. Cost $18.59 Unrealized —

— LABORATORY CORP AMER HLDGS 1.3%

Value ($000) $3,873 Shares 37,824 Est. Cost $98.22 Unrealized —

— INTRA CELLULAR THERAPIES INC 1.2%

Value ($000) $3,628 Shares 215,202 Est. Cost $17.64 Unrealized —

— TARGACEPT INC 1.0%

Value ($000) $2,841 Shares 630,000 Est. Cost $4.63 Unrealized —

— ONCONOVA THERAPEUTICS INC 0.6%

Value ($000) $1,901 Shares 350,000 Est. Cost $6.34 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	ARIAD PHARMACEUTICALS INC	12,000,000	$76,440	26.0%	$6.82	—	COM	04033A100
—	IDENIX PHARMACEUTICALS INC	2,000,000	$48,200	16.4%	$5.98	—	COM	45166R204
DGX	QUEST DIAGNOSTICS INC	775,000	$45,485	15.5%	$46.05	+0.7%	COM	74834L100
—	BIO-REFERENCE LABS INC	1,280,984	$38,711	13.2%	$27.20	—	COM $.01 NEW	09057G602
MRK	MERCK & CO INC NEW	400,000	$23,140	7.9%	$31.29	+21.3%	COM	58933Y105
—	REPROS THERAPEUTICS INC	1,003,367	$17,358	5.9%	$17.80	—	COM NEW	76028H209
—	VIVUS INC	2,573,943	$13,693	4.7%	$9.08	—	COM	928551100
AMGN	AMGEN INC	45,000	$5,327	1.8%	$83.37	0.0%	COM	031162100
—	AVEO PHARMACEUTICALS INC	2,570,759	$4,704	1.6%	$1.84	—	COM	053588109
ENTA	ENANTA PHARMACEUTICALS INC	105,000	$4,522	1.5%	$37.28	+2.3%	COM	29251M106
—	KINDRED BIOSCIENCES INC	228,126	$4,252	1.4%	$18.59	—	COM	494577109
—	LABORATORY CORP AMER HLDGS	37,824	$3,873	1.3%	$98.22	—	COM NEW	50540R409
—	INTRA CELLULAR THERAPIES INC	215,202	$3,628	1.2%	$17.64	—	COM	46116X101
—	TARGACEPT INC	630,000	$2,841	1.0%	$4.63	—	COM	87611R306
—	ONCONOVA THERAPEUTICS INC	350,000	$1,901	0.6%	$6.34	—	COM	68232V108